Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Volume XXX, No. 18 - December 26, 2023

2024: Year of Decision for FDA Regulation of LDTs

FOR OFFICIALS AT THE FEDERAL FOOD AND DRUG ADMINISTRATION (FDA), it’s been a long road to gain the power to regulate laboratory-developed tests (LDTs). It was in 2014 when the FDA sent a notice to Congress of its intention to begin regulation of LDTs. In the decade since, there has been continuing debate about whether …

2024: Year of Decision for FDA Regulation of LDTs Read More »

To access this post, you must purchase The Dark Report.

Year’s Top 10 Lab Stories Contain Surprises & Twists

CEO SUMMARY: With the SARS-CoV-2 pandemic now in the rearview mirror of the nation’s clinical labs and pathology groups, the important news stories of 2023 were mostly about developments where the consequences will influence laboratory operations in coming years. Artificial intelligence (AI) is the exception. AI is number one on The Dark Report’s “Top 10 …

Year’s Top 10 Lab Stories Contain Surprises & Twists Read More »

To access this post, you must purchase The Dark Report.

OPKO’s BioReference, Sonic Each Release Earnings Reports

BELOW IS A SUMMARY OF RECENT FINANCIAL EARNING REPORTS for OPKO’s BioReference Laboratories and Sonic Healthcare Ltd’s lab operations in the U.S. This finishes our coverage of Q3-23 financial reporting by the larger public laboratory corporations. BIOREFERENCE LABORATORIES: ‘Consistent Patient Volume’ During Q3, Compared to Prior Year Within OPKO’s third quarter conference call, data specific …

OPKO’s BioReference, Sonic Each Release Earnings Reports Read More »

To access this post, you must purchase The Dark Report.

Congress Delays PAMA Fee Cuts, Passage of SALSA Act Is Goal

ONCE AGAIN, THE CLINICAL LABORATORY INDUSTRY DODGED THE MEDICARE FEE-CUT BULLET. Last month, Congress passed a bill that included a one-year reprieve to the impending PAMA reimbursement cuts that were scheduled to take place on January 1, 2024. The lab industry caught a lucky break. On November 1, the US House of Representatives, followed by …

Congress Delays PAMA Fee Cuts, Passage of SALSA Act Is Goal Read More »

To access this post, you must purchase The Dark Report.

Violating EKRA Earns Lab Owner an Eight-Year Prison Sentence

THIS MAY BE THE MOST HIGH-PROFILE CASE involving a clinical laboratory and the Eliminating Kickbacks in Recovery Act of 2018 (EKRA). Former Arrayit Corporation president Mark Schena was sentenced in October 2023 to eight years in federal prison and ordered to pay $24 million in restitution for his role in a scheme involving healthcare fraud, …

Violating EKRA Earns Lab Owner an Eight-Year Prison Sentence Read More »

To access this post, you must purchase The Dark Report.

Why Payers Bristle as Labs Submit Inpatient Fees for Outreach Tests

        EDITOR’S NOTE: Our column, Virchow, is written by anonymous insiders working within the managed care world. The column aims to help clients of The Dark Report better understand the decisions, policies, and actions of payers as they manage their laboratory networks, establish coverage guidelines, process lab test claims, and audit labs. …

Why Payers Bristle as Labs Submit Inpatient Fees for Outreach Tests Read More »

To access this post, you must purchase The Dark Report.

December 26, 2023, Intelligence: Late-Breaking Lab News

Is the world ready for a diagnostic service that performs a whole genome sequence of embryos conceived by in vitro fertilization? That’s the business plan announced on Dec. 5 by San Francisco-based Orchid Health. In covering this development, Science wrote, “Find the embryo at lowest risk for a disease that runs in your family, touts …

December 26, 2023, Intelligence: Late-Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

;